نتائج البحث - "Nardone A."

1

Differences in Merkel cell carcinoma survival by site of primary presentation

المؤلفون: Jaehyuk Choi, Beatrice Nardone, Abu Jaafar Zaidi, Walter Liszewski

المصدر: Journal of the American Academy of Dermatology. 86:1120-1123

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Skin Neoplasms, Merkel cell carcinoma, business.industry, Dermatology, medicine.disease, Carcinoma, Merkel Cell, Internal medicine, medicine, Humans, Skin cancer, Presentation (obstetrics), business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee0aff171258879087c65a9ebebe2d7Test
https://doi.org/10.1016/j.jaad.2021.04.019Test

2

The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy

المؤلفون: Cristian Toraci, Jessica Imbrescia, Andrea Emanuele Guerini, Alessandro Magli, Salvatore Cappabianca, Luigi Spiazzi, Silvia Lucchini, Giulia Volpi, Alfonso Reginelli, Valerio Nardone, Paolo Borghetti, Stefano Maria Magrini

المساهمون: Borghetti, P., Toraci, C., Imbrescia, J., Volpi, G., Lucchini, S., Guerini, A. E., Magli, A., Spiazzi, L., Reginelli, A., Cappabianca, S., Magrini, S. M., Nardone, V.

المصدر: Annals of Nuclear Medicine. 35:1174-1176

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9346920b7b205659f97e95887898481aTest
https://doi.org/10.1007/s12149-021-01662-zTest

3

Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis

المساهمون: Nardone, V., Giannicola, R., Giannarelli, D., Saladino, R. E., Azzarello, D., Romeo, C., Bianco, G., Rizzo, M. R., Di Meo, I., Nesci, A., Pastina, P., Falzea, A. C., Caracciolo, D., Reginelli, A., Caraglia, M., Luce, A., Mutti, L., Giordano, A., Cappabianca, S., Pirtoli, L., Barbieri, V., Tassone, P., Tagliaferri, P., Correale, P.

المصدر: Life
Volume 11
Issue 11
Life, Vol 11, Iss 1235, p 1235 (2021)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b90d15be9d66293659e0c07af4932c1Test
http://europepmc.org/articles/PMC8621400Test

4

Identification of clinical phenotypes and related survival in patients with large hccs

المساهمون: Carr B.I., Guerra V., Donghia R., Farinati F., Giannini E.G., Muratori L., Rapaccini G.L., Di Marco M., Caturelli E., Zoli M., Sacco R., Celsa C., Campani C., Mega A., Guarino M., Gasbarrini A., Svegliati-Baroni G., Foschi F.G., Biasini E., Masotto A., Nardone G., Raimondo G., Azzaroli F., Vidili G., Brunetto M.R., Trevisani F., Carr, B. I., Guerra, V., Donghia, R., Farinati, F., Giannini, E. G., Muratori, L., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Sacco, R., Celsa, C., Campani, C., Mega, A., Guarino, M., Gasbarrini, A., Svegliati-Baroni, G., Foschi, F. G., Biasini, E., Masotto, A., Nardone, G., Raimondo, G., Azzaroli, F., Vidili, G., Brunetto, M. R., Trevisani, F.

المصدر: Cancers
Volume 13
Issue 4
Cancers, Vol 13, Iss 592, p 592 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, PVT, Settore MED/12 - GASTROENTEROLOGIA, Serum albumin, lcsh:RC254-282, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, Platelet, HCC, neoplasms, Survival rate, biology, business.industry, Proportional hazards model, Albumin, Hazard ratio, Settore MED/09 - MEDICINA INTERNA, Multifocality, large, phenotypes, multifocality, albumin, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, digestive system diseases, Portal vein thrombosis, Large, Phenotypes, Phenotype, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, biology.protein, business

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5527b7efef49eac4e2bc87b14e1797eaTest
http://hdl.handle.net/11577/3401939Test

5

Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

المساهمون: Marasco G., Colecchia A., Bacchi Reggiani M.L., Celsa C., Farinati F., Giannini E.G., Benevento F., Rapaccini G.L., Caturelli E., Di Marco M., Biasini E., Marra F., Morisco F., Foschi F.G., Zoli M., Gasbarrini A., Baroni G.S., Masotto A., Sacco R., Raimondo G., Azzaroli F., Mega A., Vidili G., Brunetto M.R., Nardone G., Dajti E., Ravaioli F., Avanzato F., Festi D., Trevisani F., Marasco, G., Colecchia, A., Bacchi Reggiani, M. L., Celsa, C., Farinati, F., Giannini, E. G., Benevento, F., Rapaccini, G. L., Caturelli, E., Di Marco, M., Biasini, E., Marra, F., Morisco, F., Foschi, F. G., Zoli, M., Gasbarrini, A., Baroni, G. S., Masotto, A., Sacco, R., Raimondo, G., Azzaroli, F., Mega, A., Vidili, G., Brunetto, M. R., Nardone, G., Dajti, E., Ravaioli, F., Avanzato, F., Festi, D., Trevisani, F.

مصطلحات موضوعية: Oncology, Male, Survival, Hepatocellular carcinoma, Cohort study, Hepatocellular carcinoma, Prognosis, Sorafenib, Survival, Severity of Illness Index, Antineoplastic Agent, 0302 clinical medicine, Prospective Studies, Liver Neoplasms, Gastroenterology, Middle Aged, Sorafenib, Prognosis, Treatment Outcome, Italy, Liver Neoplasm, 030220 oncology & carcinogenesis, Cohort, 030211 gastroenterology & hepatology, Female, Liver cancer, Cohort study, medicine.drug, medicine.medical_specialty, Carcinoma, Hepatocellular, Prognosi, Settore MED/12 - GASTROENTEROLOGIA, Antineoplastic Agents, Risk Assessment, 03 medical and health sciences, Internal medicine, medicine, Humans, neoplasms, Prognostic models, Neoplasm Staging, Proportional Hazards Models, Retrospective Studies, Hepatology, business.industry, Settore MED/09 - MEDICINA INTERNA, Gold standard, medicine.disease, digestive system diseases, Multicenter study, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dadf7662451833197fdc66d47ecdf02Test
http://hdl.handle.net/11577/3401821Test

6

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

المساهمون: Campani, C., Vitale, A., Dragoni, G., Arena, U., Laffi, G., Cillo, U., Giannini, E. G., Tovoli, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Sacco, R., Cabibbo, G., Mega, A., Guarino, M., Gasbarrini, A., Svegliati-Baroni, G., Foschi, F. G., Biasini, E., Masotto, A., Nardone, G., Raimondo, G., Azzaroli, F., Vidili, G., Brunetto, M. R., Farinati, F., Trevisani, F., Marra, F., Campani C., Vitale A., Dragoni G., Arena U., Laffi G., Cillo U., Giannini E.G., Tovoli F., Rapaccini G.L., Di Marco M., Caturelli E., Zoli M., Sacco R., Cabibbo G., Mega A., Guarino M., Gasbarrini A., Svegliati-Baroni G., Foschi F.G., Biasini E., Masotto A., Nardone G., Raimondo G., Azzaroli F., Vidili G., Brunetto M.R., Farinati F., Trevisani F., Marra F.

المصدر: Liver Cancer, Vol 10, Iss 2, Pp 126-136 (2021)
Liver Cancer

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c491421bcb6dda7f420bcf3554887adTest
http://hdl.handle.net/11577/3401923Test

7

Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment

المؤلفون: Roberta Grassi, Luca Boldrini, Valerio Nardone, Davide Franceschini, Daniela Greto, Carlotta Becherini, Isacco Desideri, Mauro Loi, Ilaria Morelli

المساهمون: Nardone, V., Boldrini, L., Franceschini, D., Morelli, I., Becherini, C., Loi, M., Greto, D., Desideri, I., Grassi, R.

المصدر: Cancers
Cancers, Vol 13, Iss 3590, p 3590 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3637222f8ea2f88baa87e7d486614107Test
http://europepmc.org/articles/PMC8303203Test

8

Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab

المساهمون: Nardone V., Tini P., Pastina P., Botta C., Reginelli A., Carbone S.F., Giannicola R., Calabrese G., Tebala C., Guida C., Giudice A., Barbieri V., Tassone P., Tagliaferri P., Cappabianca S., Capasso R., Luce A., Caraglia M., Mazzei M.A., Pirtoli L., Correale P., Nardone, V., Tini, P., Pastina, P., Botta, C., Reginelli, A., Carbone, S. F., Giannicola, R., Calabrese, G., Tebala, C., Guida, C., Giudice, A., Barbieri, V., Tassone, P., Tagliaferri, P., Cappabianca, S., Capasso, R., Luce, A., Caraglia, M., Mazzei, M. A., Pirtoli, L., Correale, P.

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c21ad481ff12ec2f56be93eb1d757bTest
http://hdl.handle.net/10447/513588Test

9

Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade

المؤلفون: Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano, Pierpaolo Correale

المساهمون: Nardone, V., Giannicola, R., Bianco, G., Giannarelli, D., Tini, P., Pastina, P., Falzea, A. C., Macheda, S., Caraglia, M., Luce, A., Zappavigna, S., Mutti, L., Pirtoli, L., Giordano, A., Correale, P.

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Durvalumab, Salvage therapy, Pembrolizumab, Gastroenterology, Procalcitonin, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, prognostic factors of response, medicine, cell death receptor, Lung cancer, programmed cell death ligand-1, RC254-282, Original Research, business.industry, bacterial infection, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, inflammatory markers, inflammatory marker, real-world salvage therapy, bacterial infections, immune-check point blockade, procalcitonin, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Nivolumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc2d28bc8b055476a3a290898f44b4Test
https://pubmed.ncbi.nlm.nih.gov/34195086Test

10

Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy

المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb418746950eac69ba6b54b43a53b68Test
https://www.frontiersin.org/articles/10.3389/fonc.2021.686308/fullTest

تنقيح النتائج